e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Mechanisms of respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of neutrophil apoptosis on clinical outcomes in nonresponding community-acquired pneumonia
M. J. Lorenzo, I. Moret, B. Sarria, E. Cases, E. Morcillo, M. Perpiña, R. Menendez (Valencia, Spain)
Source:
Annual Congress 2010 - Mechanisms of respiratory infections
Session:
Mechanisms of respiratory infections
Session type:
E-Communication Session
Number:
493
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. J. Lorenzo, I. Moret, B. Sarria, E. Cases, E. Morcillo, M. Perpiña, R. Menendez (Valencia, Spain). Impact of neutrophil apoptosis on clinical outcomes in nonresponding community-acquired pneumonia. Eur Respir J 2010; 36: Suppl. 54, 493
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer
Source: Eur Respir Rev 2008; 17: 83-85
Year: 2008
Impact of neutrophil function on outcomes of community-acquired pneumonia (CAP) in patients with cancer
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia
Source: Annual Congress 2004 - SARS and other lower respiratory tract infections
Year: 2004
Biomarkers and clinical stability in community-acquired pneumonia
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
Source: Eur Respir J 2004; 24: Suppl. 48, 548s
Year: 2004
Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009
An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Cytokine responses, microbial etiology and short-term outcome in community-acquired pneumonia
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017
Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia.
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia
Source: Eur Respir J 2009; 33: 142-147
Year: 2009
The impact of inflammatory-response in the outcome of trauma patients with and without ventilator-associated pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 232s
Year: 2004
Influence of antibiotic pre-treatment on inflammatory markers in community-acquired pneumonia
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008
Thrombocytosis is a marker of poor outcome in community-acquired pneumonia
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012
Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept